Development of hypertension within 2 weeks of initiation of sorafenib for advanced hepatocellular carcinoma is a predictor of efficacy.
Akutsu N, Sasaki S, Takagi H, Motoya M, Shitani M, Igarashi M, Hirayama D, Wakasugi H, Yamamoto H, Kaneto H, Yonezawa K, Yawata A, Adachi T, Hamamoto Y, Shinomura Y.
Akutsu N, et al.
Int J Clin Oncol. 2015 Feb;20(1):105-10. doi: 10.1007/s10147-014-0691-5. Epub 2014 Apr 18.
Int J Clin Oncol. 2015.
PMID: 24744262